Imaging cerebral amyloid angiopathy with susceptibility-weighted imaging

E. Mark Haacke, Z. S. DelProposto, S. Chaturvedi, V. Sehgal, M. Tenzer, J. Neelavalli, D. Kido

Research output: Contribution to journalArticle

97 Scopus citations


Gradient-echo (GE) imaging is recognized as a means to detect hemorrhagic changes in cerebral amyloid angiopathy (CAA). However, almost 25% of patients with CAA do not show microhemorrhages on T2* GE imaging. We applied a new imaging method, susceptibility weighted imaging (SWI), to evaluate the presence of microhemorrhages. In a suspected case of CAA, where cognitive effects are also present, we show that SWI is much more sensitive in detecting microhemorrhages than conventional methods.

Original languageEnglish (US)
Pages (from-to)316-317
Number of pages2
JournalAmerican Journal of Neuroradiology
Issue number2
StatePublished - Feb 1 2007
Externally publishedYes

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Imaging cerebral amyloid angiopathy with susceptibility-weighted imaging'. Together they form a unique fingerprint.

  • Cite this

    Haacke, E. M., DelProposto, Z. S., Chaturvedi, S., Sehgal, V., Tenzer, M., Neelavalli, J., & Kido, D. (2007). Imaging cerebral amyloid angiopathy with susceptibility-weighted imaging. American Journal of Neuroradiology, 28(2), 316-317.